Road traffic accidents (RTAs) represent an increasing human and socio-economic problem worldwide and have been identified as one of the target areas under the Sustainable Development Goals (SDGs) to “halve the number of global deaths and injuries from road traffic accidents” (SDG 3.6). In Sri Lanka, road traffic injuries represent one of the SD

Access to effective and affordable antibiotics remains a major challenge globally, particularly in low- and middle-income countries. To address this, SECURE, a global initiative led by World Health Organisation (WHO) and the Global Antibiotic Research and Development Partnership (GARDP) aims to work with countries to pioneer new approaches to ensur

Acknowledgements This report was prepared by Dr. Shiela Marie Selisana and Ms. Thitipanchaya Panya from the Health Intervention and Technology Assessment Program Foundation (HITAP) and reviewed by Ms. Saudamini Vishwanath Dabak. The authors are grateful to Dr. Zin Nwe Win for her invaluable as

68138067RU026L0budget impact analysis,health economic evaluation,health technology assessment,Monitoring and evaluation of high cost medicines,National List of Essential Medicines

Thailand’s dialysis policy reform, introduced in 2022, aimed to enable universal access to life-sustaining dialysis, but instead exposed systemic vulnerabilities that undermined dialysis quality, compromised patient safety and threatened sustainability of care. These outcomes highlight three ethical

© Copyright - HITAP All Rights Reserved. Health Intervention and Technology Assessment Program Foundation Head Office : 88/22 Moo 4, 6th Building, 6th Floor, Department of Health, Ministry of Public Health, Tiwanon Road, Taladkwan Subdistrict, Muang Nonthaburi Distr

Background Chronic kidney disease is a growing global health concern, requiring kidney replacement therapy for survival. In Brunei, kidney failure incidence and prevalence are among the highest globally. Despite a peritoneal dialysis preference policy, uptake remains low, straining financial and hu

การพัฒนาและประเมินชุดสิทธิประโยชน์ (ที่ไม่ใช่ยา) เพื่อสนับสนุนการเข้าถึงบริการสุขภาพของประเทศไทย เป็นการดําเนินงานที่เป็

66183067HM017L0health economic evaluation,health technology assessment,medical innovation,research and development,target product profiles

การจัดกระบวนการพัฒนาชุดสิทธิประโยชน์แบบครบวงจร ภายใต้ระบบหลักประกันสุขภาพแห่งชาติ เป็นการดำเนินงานตามที่ได้รับมอบหมายจ